Evidence map›Paper›PMID 37784195›Full record

ArticleHealth research policy and systems2023

Early implementation learnings on acceptability and feasibility of "V": a multi-level PrEP intervention designed with and for adolescent girls and young women in Zimbabwe.

Thenjiwe Sisimayi, Definate Nhamo, Kumbirai Chatora, Gwendoline Chapwanya, Tinovonga Mawoyo, Getrude Ncube, Cal Bruns, Emily L Harris, Katharine D Shelley

Open access · goldAbstract read
In one paragraph

Article in Health research policy and systems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Thenjiwe Sisimayi, Harare, Zimbabwe. thenjiwe.sisimayi@gmail.com.ORCID http://orcid.org/0000-0003-2281-1106
Definate NhamoPangaea Zimbabwe AIDS Trust (PZAT), 27 Rowland Square, Milton Park, Harare, Zimbabwe.
Kumbirai ChatoraPopulation Services International (PSI), 45 Piers Road, Sam Levy's Village Block C, Harare, Zimbabwe.
Gwendoline ChapwanyaPangaea Zimbabwe AIDS Trust (PZAT), 27 Rowland Square, Milton Park, Harare, Zimbabwe.
Tinovonga MawoyoPopulation Services International (PSI), 45 Piers Road, Sam Levy's Village Block C, Harare, Zimbabwe.
Getrude NcubeMinistry of Health and Child Care (MoHCC), 4th Floor Kaguvi Building, Harare, Zimbabwe.
Cal BrunsMatchboxology, 70, 7th Avenue, Parktown North, Johannesburg, 2193, South Africa.
Emily L HarrisUnited States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, USA.
Katharine D ShelleyPATH, Primary Health Care, 2201 Westlake Ave Suite 200, Seattle, WA, 98121, USA.
Family Aids Caring Trust · ZWPopulation Services International · INMinistry of Health and Child Welfare · ZWProgram for Appropriate Technology in Health · USScientific and Industrial Research and Development Centre · ZWUnited States Agency for International Development · US

Funding

U.S. President's Emergency Plan for AIDS Relief 7200AA18M00011U.S. President's Emergency Plan for AIDS Relief AID-OAA-A-15-00033
6 · The paper itself

Abstract

introductionAdolescent girls and young women (AGYW) remain disproportionately affected by HIV in Zimbabwe. Several HIV prevention options are available, including oral tenofovir-based pre-exposure prophylaxis (PrEP), however AGYW face unique barriers to PrEP uptake and continuation and novel approaches are therefore needed to empower AGYW to use PrEP. The objective of this study was to characterize early learnings from implementing a multi-level intervention consisting of fashionable branding (including a "V Starter Kit"), service integration, and peer education and support throughout a young woman's journey using oral PrEP across four phases of implementation, from creating demand, preparing for PrEP, initiation of PrEP, and adherence to PrEP.

methodsA mixed methods implementation research study was undertaken, including site observations and interviews to explore the acceptability of "V" and its relevance to target users, as well as the feasibility of integrating "V" with existing service delivery models. Interviews (n = 46) were conducted with healthcare workers, Brand Ambassadors, and young women purposively sampled from four implementation sites. Interview data was analyzed thematically using the framework method for qualitative data management and analysis. Project budgets and invoices were used to compile unit cost and procurement data for all "V" materials.

results"V" was acceptable to providers and young women due to attractive branding coupled with factual and thought-provoking messaging, establishing "a girl code" for discussing PrEP, and addressing a gap in communications materials. "V" was also feasible to integrate into routine service provision and outreach, alongside other services targeting AGYW. Cost for the "V" branded materials ranked most essential-FAQ insert, pill case, makeup bag, reminder sticker-were $7.61 per AGYW initiated on PrEP.

conclusion"V" is a novel approach that is an acceptable and feasible multi-level intervention to improve PrEP access, uptake, and continuation among AGYW, which works through empowering AGYW to take control of their HIV prevention needs. In considering "V" for scale up in Zimbabwe, higher volume procurement and a customized lighter package of "V" materials, while still retaining V's core approach, should be explored.

Indexed as

Anti-HIV AgentsHIV InfectionsAdolescentFeasibility StudiesFemaleHumansTenofovirZimbabweAnti-HIV AgentsTenofovirAcceptabilityAdolescent girlsFeasibilityPrEPZimbabwe

Identifiers

PMID37784195
PMCPMC10546763
OpenAlexW4387253828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.